Lajara R - Search Results

1

A solar energy powered autonomous wireless actuator node for irrigation systems.

Lajara R, Alberola J, Pelegrí-Sebastiá J. Lajara R, et al. Sensors (Basel). 2011;11(1):329-40. doi: 10.3390/s110100329. Epub 2010 Dec 30. Sensors (Basel). 2011. PMID: 22346580 Free PMC article.

2

Power consumption analysis of operating systems for wireless sensor networks.

Lajara R, Pelegrí-Sebastiá J, Perez Solano JJ. Lajara R, et al. Sensors (Basel). 2010;10(6):5809-26. doi: 10.3390/s100605809. Epub 2010 Jun 8. Sensors (Basel). 2010. PMID: 22219688 Free PMC article.

3

Fast Coincidence Filter for Silicon Photomultiplier Dark Count Rate Rejection.

Real D, Calvo D, Zornoza JD, Manzaneda M, Gozzini R, Ricolfe-Viala C, Lajara R, Albiol F. Real D, et al. Among authors: lajara r. Sensors (Basel). 2024 Mar 25;24(7):2084. doi: 10.3390/s24072084. Sensors (Basel). 2024. PMID: 38610297 Free PMC article.

4

Initiation of iGlarLixi Versus Basal-Bolus Insulin in Adults With Type 2 Diabetes Advancing From Basal Insulin Therapy: The SoliComplex Real-World Study.

Pantalone KM, Heller C, Lajara R, Lew E, Li X, Dex T, Kilpatrick CR. Pantalone KM, et al. Among authors: lajara r. Diabetes Spectr. 2023 Summer;36(3):253-263. doi: 10.2337/ds22-0064. Epub 2023 Mar 7. Diabetes Spectr. 2023. PMID: 37583559 Free PMC article.

5

iGlarLixi versus premixed insulin initiation in adults with type 2 diabetes advancing from basal insulin therapy: The SoliComplex real-world study.

Lajara R, Heller C, Pantalone KM, Lew E, Li X, Dex T, Kilpatrick CR. Lajara R, et al. Diabetes Obes Metab. 2023 May;25(5):1249-1260. doi: 10.1111/dom.14974. Epub 2023 Feb 28. Diabetes Obes Metab. 2023. PMID: 36633506

6

American Association of Clinical Endocrinology Clinical Practice Guideline: The Use of Advanced Technology in the Management of Persons With Diabetes Mellitus.

Grunberger G, Sherr J, Allende M, Blevins T, Bode B, Handelsman Y, Hellman R, Lajara R, Roberts VL, Rodbard D, Stec C, Unger J. Grunberger G, et al. Among authors: lajara r. Endocr Pract. 2021 Jun;27(6):505-537. doi: 10.1016/j.eprac.2021.04.008. Endocr Pract. 2021. PMID: 34116789

7

Sotagliflozin added to optimized insulin therapy leads to HbA1c reduction without weight gain in adults with type 1 diabetes: A pooled analysis of inTandem1 and inTandem2.

Rodbard HW, Giaccari A, Lajara R, Stewart J, Strumph PS, Oliveira J, Lapuerta P, Castro R. Rodbard HW, et al. Among authors: lajara r. Diabetes Obes Metab. 2020 Nov;22(11):2089-2096. doi: 10.1111/dom.14127. Epub 2020 Jul 28. Diabetes Obes Metab. 2020. PMID: 32618383

8

Combination therapy with SGLT-2 inhibitors and GLP-1 receptor agonists as complementary agents that address multi-organ defects in type 2 diabetes.

Lajara R. Lajara R. Postgrad Med. 2019 Nov;131(8):555-565. doi: 10.1080/00325481.2019.1670017. Epub 2019 Oct 3. Postgrad Med. 2019. PMID: 31580737 Free article. Review.

9

The MARLINA-T2D trial: putting the results into clinical perspective.

Lajara R. Lajara R. Expert Rev Endocrinol Metab. 2018 May;13(3):173-176. doi: 10.1080/17446651.2018.1455497. Epub 2018 Apr 2. Expert Rev Endocrinol Metab. 2018. PMID: 30058901 Clinical Trial.

10

The role of the new basal insulin analogs in addressing unmet clinical needs in people with type 1 and type 2 diabetes.

Lajara R, Cengiz E, Tanenberg RJ. Lajara R, et al. Curr Med Res Opin. 2017 Jun;33(6):1045-1055. doi: 10.1080/03007995.2017.1298522. Epub 2017 Mar 24. Curr Med Res Opin. 2017. PMID: 28277867 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

26 results

Search Page

Filters